United States Pharmaceuticals

Orchard Therapeutics PLC (ORTX)

Track

Ticker: ORTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Orchard Therapeutics PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.6
Gaspar Bobby Chief Executive Officer Executive Director
Transaction date
Purchase
Price
402.07
Quantity 87,480 +6.2%
Value US$4,938,046
1.4
THOMAS FRANK E See Remarks Officer
Transaction date
Purchase
Price
192.68
Quantity 27,819 -46.8%
Value US$431,705
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
427.46
Quantity 71,349 -30.5%
Value US$3,464,358
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
6.98
Quantity 1,022,755 -16.7%
Value US$7,138,830
0.6
Gaspar Bobby See Remarks Executive Director
Transaction date
Planned sale
Price
13.00
Quantity 4,921 -1.4%
Value US$63,973
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
13.55
Quantity 5,484 -0.1%
Value US$74,308
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
13.41
Quantity 8,753 -0.1%
Value US$117,378
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
13.55
Quantity 5,484 -0.1%
Value US$74,308
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-05 2022-04-01 B Purchase
0.6
Gaspar Bobby

Chief Executive Officer

Executive Director
87,480 +6.2%
402.07
US$4,938,046 		87,480 +6.2% 402.07 US$4,938,046
2022-04-04 2022-04-01 B Purchase
1.4
THOMAS FRANK E

See Remarks

Officer
27,819 -46.8%
192.68
US$431,705 		27,819 -46.8% 192.68 US$431,705
2021-02-10 2021-02-05 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
71,349 -30.5%
427.46
US$3,464,358 		71,349 -30.5% 427.46 US$3,464,358
2021-02-10 2021-02-05 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
1,022,755 -16.7%
6.98
US$7,138,830 		1,022,755 -16.7% 6.98 US$7,138,830
2020-11-06 2020-09-24 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
473,327 +5.0%
4.61
US$2,182,037 		473,327 +5.0% 4.61 US$2,182,037
2020-11-06 2020-08-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
10,226 +0.1%
4.51
US$46,119 		10,226 +0.1% 4.51 US$46,119
2020-11-06 2020-08-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
54,416 +0.6%
4.64
US$252,490 		54,416 +0.6% 4.64 US$252,490
2020-11-06 2020-08-20 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
4,525 +0.0%
4.61
US$20,860 		4,525 +0.0% 4.61 US$20,860
2020-11-06 2020-08-20 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
58,106 +0.6%
4.61
US$267,869 		58,106 +0.6% 4.61 US$267,869
2020-11-06 2020-08-19 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
9,050 +0.1%
4.65
US$42,082 		9,050 +0.1% 4.65 US$42,082
2020-11-06 2020-08-19 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
55,204 +0.6%
4.69
US$258,907 		55,204 +0.6% 4.69 US$258,907
2020-11-06 2020-08-18 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
45,249 +0.5%
4.72
US$213,575 		45,249 +0.5% 4.72 US$213,575
2020-11-06 2020-08-17 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
8,235 +0.1%
4.74
US$39,034 		8,235 +0.1% 4.74 US$39,034
2020-11-06 2020-08-14 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
13,031 +0.1%
4.74
US$61,767 		13,031 +0.1% 4.74 US$61,767
2020-11-06 2020-08-12 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
16,291 +0.2%
4.74
US$77,219 		16,291 +0.2% 4.74 US$77,219
2020-11-06 2020-08-10 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
6,787 +0.1%
4.71
US$31,967 		6,787 +0.1% 4.71 US$31,967
2020-11-06 2020-08-10 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
14,570 +0.2%
4.75
US$69,208 		14,570 +0.2% 4.75 US$69,208
2020-03-04 2020-03-02 PlS Planned sale
0.6
Gaspar Bobby

See Remarks

Executive Director
4,921 -1.4%
13.00
US$63,973 		4,921 -1.4% 13.00 US$63,973
2020-01-06 2020-01-02 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
5,484 -0.1%
13.55
US$74,308 		5,484 -0.1% 13.55 US$74,308
2020-01-06 2020-01-02 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
8,753 -0.1%
13.41
US$117,378 		8,753 -0.1% 13.41 US$117,378
2020-01-06 2020-01-02 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
5,484 -0.1%
13.55
US$74,308 		5,484 -0.1% 13.55 US$74,308
Explore more

More insider trading research around Orchard Therapeutics PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America